Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial
Philip Quirke(University of Leeds), David Sebag‐Montefiore(University of Leeds), Mahesh Parmar(University College London), Arthur Sun Myint(University of Liverpool), R. Steele(University of Dundee), E.M. Bessell(University Hospitals Birmingham NHS Foundation Trust), Lindsay C Thompson(MRC Clinical Trials Unit at UCL), Richard Stephens(Keele University), Subhash Khanna(Leicester Royal Infirmary), Robert Grieve, John R.T. Monson(Northwell Health), Jean Couture(Ontario Institute for Cancer Research), Chris J. O’Callaghan(Unknown)
Cited by 1,050
Related Papers
<i>K-ras</i> Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer
|New England Journal of Medicine|2008|3.6k
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
|European Heart Journal|2022|2.7k
Cetuximab for the Treatment of Colorectal Cancer
|New England Journal of Medicine|2007|1.8k
Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy
|New England Journal of Medicine|2017|1.8k